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Rheumatoid Arthritis (RA) is a chronic autoimmune dis-
ease that affects approximately 0.3-1% of people world-
wide.1 RA is characterised by high-grade local and sys-
temic inflammation, which leads to severe joint pain, 
stiffness and swelling in synovial joints of the body.2-4 
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ABSTRACT
Background: Sedentary behaviour (SB) is associated with adverse health outcomes in the general 
population. Replacing sedentary time with light intensity physical activity (LPA) has been linked with im-
provements in all-cause and cardiovascular disease mortality in adults. People with Rheumatoid Arthritis 
(RA) typically spend long periods of time sedentary, but the health consequences of ‘too much sitting’, 
and possible benefits of LPA, have not been fully explored in this population. Moreover, little is known 
regarding the determinants of these behaviours among people living with RA, and such knowledge 
is required for the development of effective behavioural interventions. Aims: To examine longitudinal 
relationships between: 1) objectively-assessed SB/LPA with health outcomes in RA, 2) hypothesised 
determinants of SB/LPA with objectively-assessed SB/LPA in RA. Methods: This longitudinal study 
will secure assessments at baseline (Time 1) and 6-month follow-up (Time 2) from RA patients. At both 
time points, physical assessments will be undertaken, and questionnaires administered to measure 
physical (e.g., percentage body fat, disease activity, physical function, pain) and psychological (e.g., 
depression, anxiety, vitality) health outcomes. Additional questionnaires will be administered to estab-
lish hypothesised determinants (i.e., psychosocial, individual differences, and physical environmental). 
Participants will wear the ActiGraph GT3X accelerometer and activPAL3μTM for 7 days to objectively 
measure SB and LPA. Discussion: Findings will elucidate the health correlates of SB in RA, as well 
as the relevance of interventions targeting reductions in SB by promoting LPA. Results will also assist 
in identifying intervention targets (i.e., determinants), with the potential to encourage SB change in RA.
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People living with RA are exposed to a 50% increase in 
cardiovascular risk,5 with heightened universal inflamma-
tion implicated in the common development of cardio-
vascular disease (CVD) -related morbidity and mortality 
in this patient group.6,7-9 In addition, this elevated inflam-
mation contributes to an increased risk of poor mental 
health in RA.10
Sedentary Behaviour
Sedentary behaviour (SB) is defined as ‘any waking be-
haviour characterised by an energy expenditure ≤1.5 
metabolic equivalents (METS) while in a sitting, reclining, 
or lying posture’.11,12 It is distinct from physical inactivi-
ty, which refers to lack of regular engagement in mod-
erate-to-vigorous intensity physical activity (MVPA [≥3 
METS]) in accordance with physical activity recommen-
dations (i.e., 30 minutes x 5 days per week for adults). 
Examples of common SBs include sitting watching tele-
vision, reading a book, working at a computer and trav-
elling in a vehicle.13 In the general population, SB has 
been consistently associated with increased inflamma-
tion, and it has been proposed that this may represent 
a mechanism through which SB leads to an increased 
risk of poor health.14,15 For example, prospective stud-
ies demonstrate high levels of SB to associate with 
worsened cardiovascular and cardiometabolic health; 
both of which are linked to heightened systemic inflam-
mation.16-25 In addition, a recent systematic review and 
dose-response meta-analysis reported that total sitting 
time and television viewing time were associated with a 
greater risk of several major chronic disease outcomes, 
including all-cause, CVD, and cancer mortality, as well 
as incident diabetes.26 Importantly, such adverse health 
outcomes associated with engagement in SB have been 
shown to occur, despite the level of MVPA an individual 
engages in.27,28 That is, SB represents an independent 
risk factor for poor health.26
Sedentary Behaviour and Rheumatoid Arthritis
It has been reported that people living with RA typical-
ly spend long periods of time sedentary,3,29,30 and recent 
accelerometry studies suggest people with this condition 
can spend up to 9 waking hours sedentary per day.31,32 
On the basis of emerging evidence for the association 
between SB and inflammation, Fenton and Kitas29 hy-
pothesised that high levels of SB in RA may exacerbate 
already elevated systemic inflammation in these patients, 
and contribute to the progression of RA outcomes. Akin 
to this proposition, Fenton et al.31 summarised results 
of non-RA studies, demonstrating the adverse links be-
tween SB with inflammation and chronic diseases with an 
inflammatory component (e.g., CVD, type 2 diabetes), un-
derlining the relevance of these findings for RA. That is, as 
evidence for the associations between SB, inflammation 
and poor health continues to accumulate, it is important 
to evaluate the role of SB as an independent risk factor 
for disease outcomes in RA – a population experiencing 
compromised health and at high risk of comorbidity. 
Whilst studies to date are yet to determine the role of SB 
for inflammation in RA, research has begun to examine 
the implications of SB for broader RA outcomes. Such 
investigations have employed either device-based, or 
self-report methods to quantify SB. For example, Khoja 
et al.33 reported positive associations between acceler-
ometer-assessed SB with disease activity, and Greene et 
al.34 and Giles et al.35 showed that high levels of self-re-
ported SB was associated with poorer physical function 
in RA patients. In addition, Prioreschi et al.3 used accel-
erometry to determine SB patterns in people living with 
RA and found an inverse association between SB and 
bone mass. More recently, research studies have indi-
cated that higher levels of accelerometer-assessed SB 
are associated with more pain and fatigue,36 and a higher 
risk of CVD.37 Specifically, Fenton et al.37 found that total 
sedentary time was adversely associated with 10-year 
CVD risk in a sample of RA patients. Interestingly, this 
study was the first to examine whether the manner in 
which sedentary time was accumulated held implications 
for health outcomes in RA. Findings revealed a positive 
relationship between sedentary time accumulated in 
bouts ≥20 minutes and 10-year CVD risk. 
This finding37 is aligned with novel prospective and ex-
perimental studies, which indicate that shorter sedentary 
bouts (i.e., the duration of uninterrupted sedentary peri-
ods) and more frequent sedentary breaks (i.e., interrup-
tions in sedentary time)with light physical activity (LPA 
[1.6 – <3 METS]), are beneficially linked to health out-
comes in non-clinical and clinical populations.20,27,38-43 For 
example, regularly breaking up SB with LPA has been 
associated with better cardiometabolic and cardiovas-
cular health in adults (≥20 years)20,38 and older adults,27 
and has also been linked with a reduced risk of disabili-
ty among older adults.41 A recent systematic review and 
meta-analysis of experimental and observational studies 
also revealed that LPA (overall, and sedentary breaks) 
could play a role in improving adult cardiometabolic 
health and reducing mortality risk.44 In RA, recent studies 
have reported beneficial associations between daily LPA 
with CVD risk,37 depression and vitality.45
Such findings illustrating the potential health benefits of 
LPA are particularly relevant to people with RA, given the 
pain and physical dysfunction characteristic of this con-
dition. Indeed, approaches to reduce SB by promoting 
LPA (‘sedentary breaks’), may be better tolerated than 
those targeting MVPA, the traditional focus of physical 
activity behaviour change interventions in this patient 
group. Moreover, the strong inverse correlation between 







to the potential of behavioural interventions which aim to 
displace SB with LPA among this population.33,45 
Whilst studies on this topic are beginning to emerge, a 
number of important limitations mark the extant literature 
in this field, which should be addressed in future research. 
First, a heavy reliance on self-report measures to assess 
SB and physical activity within this patient group brings 
issues regarding social desirability, errors in participant 
recall, and a tendency to underestimate levels of SB and 
overestimate levels of physical activity.16,46 Second, whilst 
several studies have employed accelerometers in an at-
tempt to address the limitations of self-report, sedentari-
ness is often incorrectly defined as activity ≤1 MET33 or <1 
MET.47 As a result, SBs that require between 1-1.5 METS 
(e.g., sitting whilst watching television or reading) may be 
misclassified as LPA,48,49 meaning the true significance of 
SB for RA outcomes cannot be accurately determined. 
Similarly, SB is sometimes defined as ‘lack of engagement 
in purposeful physical activity’ (i.e., physical inactivity, not 
meeting MVPA guidelines), which is inconsistent with the 
definition used by the SB Research Network (i.e., waking 
behaviour ≤1.5 METS, whilst sitting/reclining/lying),11,12 
employed almost globally across the SB literature. Finally, 
the majority of studies that identify associations between 
SB and health outcomes in RA are cross-sectional, pos-
ing a challenge when inferring a causal direction of these 
associations.31 As such, research is required to address 
these methodological limitations, and generate important 
knowledge regarding the consequences of SB in RA for 
inflammatory burden and related RA outcomes. It is also 
essential that high quality studies investigate the potential 
benefits of LPA participation for people living with RA, in 
order to elucidate the potential relevance of interventions 
that focus on displacing SB with LPA. 
Determinants of Sedentary Behaviour and Light 
Physical Activity
In order to prevent the potential adverse consequenc-
es of SB for health in RA, interventions promoting SB 
change should target factors that influence this be-
haviour (i.e., determinants). If interventions are to focus 
on displacing SB with engagement in LPA, they will also 
need to consider the determinants of LPA.
Psychosocial determinants and individual 
difference factors
Self-efficacy. Social Cognitive Theory (SCT)50 regular-
ly serves as the theoretical basis for health behaviour 
change interventions.51 Self-efficacy (i.e., situational-spe-
cific confidence), an underlying composite of SCT, has 
been identified as a consistent predictor of physical ac-
tivity engagement.51 Indeed, it has been well document-
ed that self-efficacy is a significant determinant for the 
adoption and adherence of physical activity in different 
populations.52-54 Contrastingly, few studies have consid-
ered self-efficacy as a determinant for SB change, par-
ticularly in the RA population. One study by Huffman and 
colleagues47 indicated that self-efficacy for exercise was 
negatively and positively associated with SB and phys-
ical activity respectively in this patient group. As high-
lighted above, a criticism of this study is that an incorrect 
definition of SB as <1 MET was employed.
Quality of motivation. Self-Determination Theory (SDT)55 
proposes that variability in the reasons ‘why’ a person 
chooses to engage (or not to engage) in a behaviour, holds 
important implications for levels of engagement. Specifical-
ly, SDT suggests that an individual’s motivation may vary 
in its degree of relative autonomy, with more autonomous 
reasons for engagement (e.g., fun, enjoyment, personal-
ly important) linked to an increased likelihood of adopting 
and persisting with engagement in a behaviour (e.g., phys-
ical activity). In contrast, more controlled reasons for par-
ticipation (e.g., other people’s approval, feeling guilty) are 
linked to a lesser chance of sustaining behaviour. The im-
plications of quality of motivation have been demonstrated 
in a considerable amount of physical activity research with 
different populations,56 including RA.57
SDT also postulates that humans have three basic psy-
chological needs; namely, autonomy, competence and 
social relatedness. Fulfilment of these needs leads to fos-
tering more autonomous motivation towards a behaviour, 
as well as benefits in mental health (e.g., vitality and well-
being).58 SDT suggests the social environment is central 
to the satisfaction of these three basic needs, and holds 
implications for encouraging behaviour change through 
promoting more autonomous motivation. Specifically, the 
provision of autonomy support from an ‘important oth-
er’ (e.g., peer, parent, spouse, health professional) is re-
ported to hold positive implications for need satisfaction, 
quality of motivation and behavioural engagement.59-62 
Fenton et al.45 demonstrated perceptions of autonomy 
support from an ‘important other’ to be positively asso-
ciated with LPA, in turn benefiting psychological health 
(i.e., depression and vitality), in RA patients. However, no 
studies have examined the role of the basic psycholog-
ical needs and quality of motivation in this relationship, 
nor have the determinants of SB accumulation been 
explored in the RA population through a SDT lens. For 
example, it is possible that more autonomous motivation 
for reducing SB (e.g., identification with health benefits) is 
associated with lower levels of sedentariness.
Physical environmental determinants
The physical environment has been identified as a mod-
ifiable determinant of SB.63 Furthermore, the Systems of 
SBs framework emphasises the importance of prioritis-
ing investigation into physical environmental factors, and 
their relationship with SB accumulation in different popu-
lations. Distinguishing between specific factors within the 
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physical environment (e.g., home, workplace, neighbour-
hood) has been stressed as important when examining 
the determinants of SB, in order to ensure interventions 
can be properly targeted. At present, research studies 
examining the physical environmental determinants of 
SB often fail to be domain-specific, which can lead to 
contradicting evidence.63
The Systems of SBs framework also depicts that ele-
ments of the physical environment may influence SB 
engagement in different ways, among different popula-
tions. For example, examining the determinants of SB in 
the workplace might not be as relevant to an older adult 
population as the home or neighbourhood environment 
might be.63 Indeed, aspects of the home environment, 
such as the number of televisions and motorised vehi-
cles, have been positively correlated with levels of SB in 
adults (mean age = 57.5 years).63 Furthermore, aesthetic 
features outside of the home environment (e.g., public 
parks, trees) have been inversely associated with lei-
sure-time SB in adults (mean age = 52.2 years).65
To date, no studies have investigated the physical envi-
ronmental correlates of SB and LPA in the RA population. 
This patient group is highly heterogeneous, representing 
different ages, variability in disease activity, physical func-
tion and employment status. This underlines the need 
to examine physical environmental determinants across 
multiple domains of SB and LPA engagement (i.e., in the 
home, workplace and neighbourhood).
Aims of this research
This study will address the knowledge gaps and limita-
tions of the existing literature, in order to build an ev-
idence base regarding the health-related correlates of 
SB and LPA, and hypothesised determinants of these 
behaviours in RA. 
The aims of this study are twofold: 
1) To investigate the longitudinal relationships between 
objectively-assessed SB patterns (i.e., overall sedentary 
time, sedentary bouts and sedentary breaks) and LPA, 
with health outcomes in people living with RA. On the ba-
sis of evidence establishing an association between SB 
and inflammation in non-RA cohorts, we hypothesise that 
SB may contribute to disease outcomes in RA via perpet-
uating heightened systemic inflammation. As such, our 
primary health outcomes are: inflammatory biomarkers 
(e.g., Tumour Necrosis Factor-alpha [TNF-a], Interleukin 
6 [IL-6], high-sensitivity C-Reactive Protein [CRP], Eryth-
rocyte Sedimentation Rate [ESR]), which have previously 
been used as primary endpoints in non-RA studies ex-
amining the association between SB, inflammation and 
health.14,15 Secondary health outcomes are: broader dis-
ease-related outcomes (e.g., disease activity, CVD risk, 
pain, fatigue, physical function), indices of psychological 
wellbeing (e.g., depression, anxiety, vitality, satisfaction 
with life, positive and negative affect), and quality of life.
2) To examine the longitudinal associations between hy-
pothesised determinants (i.e., psychosocial [e.g., auton-
omy support], individual differences [e.g., self-efficacy] 
and physical environmental [e.g., home and neighbour-
hood environment]) of SB and LPA (i.e., for: 1) reducing 
overall SB, 2) regularly breaking up SB and 3) physical 
activity), with objectively-assessed SB patterns (i.e., 
overall sedentary time, sedentary bouts and sedentary 
breaks) and LPA, in people living with RA.
METHODOLOGY
Participants and Recruitment
Participants will be recruited from Rheumatology Outpa-
tient Clinics in a hospital in Dudley, England. Inclusion 
criteria will be: a clinical diagnosis of RA according to the 
American College of Rheumatology-European League 
Against Rheumatism (ACR-EULAR) Criteria and aged 
≥18 years old. Exclusion criteria will be: wheelchair us-
ers and those unable to ambulate independently with the 
use of an assistive device. 
Eligible patients will be approached about the study 
during Rheumatology Outpatient Clinics. A member of 
the research team will provide patients with information 
about study procedures and patients will be given the 
opportunity to ask the researcher any questions. Willing 
patients will provide informed consent to participate in 
the study. This study has been approved by the local Na-
tional Health Service Research Ethics Committee (West 
Midlands – Black Country Research Ethics Committee 
16/WM/0371).
Protocol
This study will adopt a longitudinal design. Participants 
will be asked to visit the hospital at 2 time points; base-
line (Time 1) and 6-month follow-up (Time 2). At each 
time point, participants will be asked to undertake 2 visits 
(i.e., visits 1 and 2) separated by a 7-day period. Specific 
protocols to be followed are described below. 
Visit 1
Participants will visit the hospital to undertake physical 
assessments and complete questionnaires. At the end 
of Visit 1, participants will be fitted with the ActiGraph 
(GT3X) accelerometer and activPAL3μTM posture sensor 
to wear for the subsequent 7 days. The researcher will 
give verbal and written instructions, plus a demonstra-
tion, regarding how to wear each device. Participants 
will also be given the Bouchard Physical Activity Record 
(BAR)66 to complete on 3 of the days during which they 
wear the GT3X and activPAL3μTM. 
Visit 2
After 7 days, participants will re-visit the hospital to pro-
vide a fasted blood sample, and return the GT3X accel-
erometer, activPAL3μTM posture sensor and BAR to the 
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researcher. During this visit, they will also be asked to 
complete questionnaires with specific reference to their 
experiences of pain and fatigue over the previous 7 days.
Measures
Visit 1
Participant characteristics. Information will be recorded per-
taining to participants’ age, gender, ethnicity, marital status, 
education, date of diagnosis, existing chronic conditions 
(e.g., heart disease, diabetes, depression), current medical 
treatment, smoking status and living arrangements.
Anthropometrics. Taken in duplicate, height, weight and 
body composition will be measured with participants 
bare-foot, whilst wearing light and loose-fitting clothing.  
Height will be measured to the nearest 0.1cm using a 
stadiometer (SECA, Leicester Height Measure). Weight 
will be measured to the nearest 0.1kg using the Tanita 
Body Composition Scales (Tanita BC-418 MA P). Body 
Mass Index (BMI) will be calculated as weight (kg)/height2 
(m2). Percent body fat and muscle mass will be mea-
sured using the Tanita Scales via bioelectrical impedance 
analysis.
Resting blood pressure. Resting blood pressure (systolic 
and diastolic) will be taken in duplicate with an automatic 
blood pressure machine (Mindray Accutorr PLUS). The 
blood pressure cuff will be placed over the brachial artery 
as standard, after the participant has rested in a supine 
position for 5 minutes.36,67
Physical function. Gait speed will be assessed using the 
20-Metre Timed Walk Test to provide an objective mea-
sure of physical function. Participants’ time to walk from 
a ‘start line’ to a ‘finish line’, 20 metres apart, will be re-
corded using a stopwatch. The stopwatch will be start-
ed once the participant begins to walk from the ‘start 
line’, and will be stopped once the participant’s heel has 
completely crossed the ‘finish line’. Gait speed has been 
previously used in studies of RA to provide an objective 
measure of physical function (e.g., walking 15.24 me-
tres).68 Research has also shown that slower gait speed 
is associated with RA outcomes, such as pain, fatigue 
and joint deformation.69 As such, it may also serve as a 
proxy for other important aspects of RA health, directly 
related to physical function.
Questionnaires. Validated questionnaires will be admin-
istered to the participant to assess self-reported RA 
outcomes and hypothesised determinants of SB and 
physical activity (see Table 1). Questionnaire scores will 
be calculated according to validated scoring instructions 
(e.g., mean scores will be calculated for the ‘autonomous 
motivation for reducing SB’ dimension in the Behavioural 
Regulation in Exercise Questionnaire-2). 
Actigraph GT3X. The GT3X triaxial accelerometer (27g; 
3.8cm x 3.7cm x 1.8cm) will be attached to an adjustable 
elastic belt and worn on the right hip in a vertical position.70-74 
Participants will be asked to remove the device only for sleep-
ing and water-based activities (e.g., swimming, bathing), and 
to record all replacement/removal in wear time logbooks 
provided. The GT3X will record accelerations in 1-second 
epochs, which will be converted into activity counts. These 
counts will then be interpreted to determine the frequency, 
intensity and duration of SB and physical activity. 
Data collected by the GT3X will be cleaned and analysed 
using Actilife Software (version 6). For inclusion in analy-
ses, participants will be required to have worn the GT3X 
for ≥4 days, for ≥10 hours per day, including a weekend 
day.25,75-78 Non-wear (e.g., 60 minutes of ‘zero counts’) will 
be defined in accordance with previous research among 
older adults75,78 and people living with RA.45 Time spent 
in SB, LPA and MVPA will be determined using cut-points 
that have been validated in previous research with adults 
(e.g., Troiano et al.),74 and used in studies investigating 
SB and physical activity in the general population,79 in 
people with rheumatic diseases80 and in osteoarthritis.81
ActivPAL3μTM. The activPAL3μTM posture sensor (9g; 
2.35cm x 4.3cm x 0.5cm) will be initialised using ac-
tivPAL3μTM software and attached by the researcher to 
the front of the right thigh, in a mid-anterior position, with 
a waterproof, adhesive Tegaderm dressing. Participants 
will be asked to wear the activPAL3μTM for 24 hours a day 
to enable assessment of time spent sitting/lying, stand-
ing and stepping, as well as sit-to-stand transitions.82-85 
activPAL3μTM software will be used to download the ac-
tivPAL3μTM data. Sleep time will be determined using 
self-reported information from the wear time logbooks 
and BAR, in conjunction with non-wear periods identi-
fied via algorithms applied to GT3X data. Specifically, the 
GT3X output generated by Actilife details at which time 
the participant removes (e.g., at bedtime) and replaces 
(e.g., at waking) the accelerometer throughout the 7-day 
period. This will be checked against the BAR, which 
details (over 3 days) when the participant woke up and 
went to bed. 
Participants will be required to have worn the ac-
tivPAL3μTM for ≥4 days, for ≥10 hours per day, including a 
weekend day, to be included in analyses.76,86-88 Variables 
derived for analyses will include: time spent sitting/lying, 
standing and stepping (i.e., hours per day), as well as the 
number of sit-to-stand transitions (i.e., sedentary breaks 
per day).
Bouchard Physical Activity Record. Participants will be 
asked to self-report the dominant activity undertaken ev-
ery 15 minutes, over 3 days of the study week, including a 
weekend day (e.g., Thursday, Friday and Saturday).66,89,90 
They will be asked to report this information in real-time, in 
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Table 1. Questionnaires administered at baseline (Time 1) and 6-month follow-up (Time 2), specifically on visit 1 to the 
hospital
Outcome Questionnaire Description Example
Pain McGill Pain Questionnaire
Questions pertaining to the past 2 weeks
•	 	17 items
-  Sensory descriptors 
-  Affective descriptors 
-  Present pain 
-  Average pain
•	 	For each of these words, please place a tick in one 
column:
-  E.g., Throbbing
-  (0 = none, to 3 = severe)
Fatigue Multidimensional Assessment 
of Fatigue Scale
Questions pertaining to the past 2 weeks
•	 	16 items
•	 	4 dimensions:
-  E.g., Degree and severity
•	 	Global fatigue index
•	 	Please complete the following items based on the past 
2 weeks:
-  E.g., To what degree have you experienced fatigue? 
-  (1 = not at all, to 10 = a great deal)
Fatigue Multidimensional Fatigue 
Inventory
Questions pertaining to the past 2 weeks
•	 	20 items
•	 	5 dimensions:
-  E.g., Physical fatigue
•	 	Over the past 2 weeks:
-  E.g., I feel fit
-  (1 = yes that is true, to 5 = no that is not true)
Physical function Health Assessment Ques-
tionnaire
Questions pertaining to the past 2 weeks
•	 	8 categories:
•	 	Self-reported ability to complete activities of daily 
living
-  E.g., Dressing and Grooming
•	 	Are you able to:
-  E.g., Dress yourself, including tying shoelaces and 
doing buttons?
-  (0 = without any difficulty, to 3 = unable to do)
Physical function Dartmouth Coop Functional 
Assessment Charts
Questions pertaining to the past 2 weeks
•	 	6 items
•	 	6 dimensions:
-  E.g., Physical fitness
•	 	During the past 2 weeks:
-  E.g., what was the hardest physical activity you could 
do for at least 2 minutes? 
-  (1 = very heavy, to 5 = very light)
Sleep Pittsburgh Sleep Quality 
Index
Questions pertaining to the past 2 weeks
•	 	18 items
•	 	Aspects of sleep
-  E.g., Sleep disturbances
•	 	Global sleep index
•	 	In the past 2 weeks:
-  E.g., How often have you had trouble sleeping be-
cause you have to get up to use the bathroom?
-  (0 = not during the past 2 weeks, to 3 = three or more 
times a week)
Satisfaction with life Satisfaction With Life Scale
Questions pertaining to the present time
•	 	5 items
•	 	Satisfaction with life
•	 	I currently feel:
-  E.g., In most ways, my life is close to my ideal
-  (1 = strongly disagree, to 7 = agree)
Vitality Subjective Vitality Scale
Questions pertaining to the past 2 weeks
•	 	6 items
•	 	Vitality
•	 	Over the past 2 weeks, generally:
-  E.g., I have been feeling alive and vital
-  (1 = not at all true, to 7 = very true)
Anxiety and depression Hospital Anxiety and Depres-
sion Scale
Questions pertaining to the past 2 weeks
•	 	14 items
•	 	Depression (7 items)
•	 	Anxiety (7 items)
•	 	Over the past 2 weeks:
-  E.g., I still enjoy the things I used to enjoy 
-  (0 = definitely as much, to 3 = not at all)
Positive and negative affect Positive and Negative Affect 
Schedule
Questions pertaining to the past 2 weeks
•	 	20 items
•	 	Words describing different feelings/emotions
•	 	Over the past 2 weeks:
-  E.g., Interested
-  (1 = very slightly or not at all, to 5 = extremely)
Quality of life World Health Organisation 
Quality Of Life Scale
Questions pertaining to the past 2 weeks
•	 	26 items
•	 	4 domains:
-  E.g., Physical health
•	 	Thinking about the past 2 weeks:
-  E.g., How would you rate your quality of life? 







order provide information regarding the context in which 
SB and physical activity were undertaken. For this study, 
the BAR has been adapted to include visual analogue 
scales, in which participants will be asked to report their 
average, minimum and maximum pain and fatigue on each 
of the 3 days. Specifically, at the end of each day, partici-
pants will be asked to mark a vertical line along a 100mm 
continuum from ‘no pain/fatigue’ to ‘extreme pain/fatigue’.
Visit 2
Fasted blood sample. Blood will be taken from the inside 
of the arm and collected in appropriate vacutainers. Stan-
dard laboratory procedures and Enzyme-Linked Immuno-
sorbent Assays (ELISAs) will be used to measure: serum 
biomarkers of inflammation (i.e., TNF-a, IL-6, high-sensi-
tivity CRP, ESR), plasma lipids (i.e., total cholesterol, high- 
density lipoprotein cholesterol, low-density lipoprotein 
cholesterol, triglycerides), plasma glucose and insulin. 
Determinant Questionnaire Description Example
Support from partici-
pant-identified other for 
physical activity, reducing 
sedentary behaviour and 
breaking up sitting time
Important Other Climate 
Questionnaire
•	 	6 items
-  Perceived autonomy support from important other 
regarding physical activity, reducing sedentary 
behaviour and breaking up sitting time
•	 	With regards to being physically active/reducing my 
sedentary behaviour/breaking up my sitting time:
-  E.g., I feel that my important other provides me with 
choices and options about reducing my sedentary 
behaviour
-  (1 = strongly disagree, to 7 = strongly agree)
Support from consultant for 
physical activity, reducing 
sedentary behaviour and 
breaking up sitting time
Health Care Climate Ques-
tionnaire
•	 	 6 items
-  Perceived autonomy support from consultant 
regarding physical activity, reducing sedentary 
behaviour and breaking up sitting time
•	 	With regards to being physically active/reducing my 
sedentary behaviour/breaking up my sitting time:
-  E.g., I feel that my consultant understands how I 
see things with respect to reducing my sedentary 
behaviour 
-  (1 = strongly disagree, to 7 = strongly agree)
Need satisfaction for physi-
cal activity
Psychological Need Satisfac-
tion For Exercise Scale
Questions pertaining to the past 4 weeks
•	 	18 items
-  Personal experiences of physical activity
•	 	With regards to my experiences of physical activity:
-  E.g., I feel free to do physical activity in my own way
-  (1 = false, to 6 = true)
Self-efficacy for physical 
activity and breaking up 
sitting time
Self-Efficacy for Exercise 
Scale
•	 	9 items
-  Extent of self-efficacy to take part in physical 
activity in different situations
-  Extent of self-efficacy to break up sitting time in 
different situations
•	 	How confident would you feel taking part in physical 
activity (e.g., walking) 3 times per week for 20 minutes if:
-  E.g., You felt pain when being physically active
-  (1 = not confident, to 10 = very confident)
•	 	How confident would you feel breaking up your sitting 
time every 20 minutes if:
-  E.g., You did not enjoy breaking up your sitting time
-  (1 = not confident, to 10 = very confident)
Motivation for physical 
activity, reducing sedentary 
behaviour and breaking up 
sitting time
Behavioural Regulation in 
Exercise Questionnaire-2
Questions pertaining to the past 4 weeks
•	 	19 items
-  Reasons for taking part in physical activity, 
reducing sedentary behaviour and breaking up 
sitting time
•	 	5 dimensions:
-  Intrinsic regulation (autonomous motivation)
-  Identified regulation (autonomous motivation)
-  Introjected regulation (controlled motivation)
-  External regulation (controlled motivation)
-  Amotivation
•	 	I take part in physical activity/reduce my sedentary 
behaviour/break up my sitting time:
-  E.g., Because it is fun
-  E.g., Because I value the benefits of doing this
-  E.g., Because I feel guilty when I am not doing this
-  E.g., Because other people say I should
-  E.g., But I don’t see why I should
Motivation to limit screen 
time
Motivation to Limit Screen 
Time Questionnaire
Questions pertaining to the past 4 weeks
•	 	9 items
-  Feelings/beliefs regarding screen-time behaviour in 
leisure time
•	 	I try to limit my screen-time because:
-  E.g., I believe too much screen time is bad for my 
health
-  (1 = not true at all, to 7 = very true)
Environmental perceptions 
– active travel and physical 
activity 
Assessing Levels of Physical 
Activity Scale
•	 	3 sections
-  Home and neighbourhood environment 
-  Walkability
•	 	About how long would it take to get from your home 
to the nearest businesses or facilities listed below if 
you walked to them?
-  E.g., Supermarket
-  (1 = 1-5 min, to 5 = more than 30 min)
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Disease activity score-28. The number of swollen and 
tender joints in 28 joints of the body (i.e., hands, wrists, 
elbows, shoulders and knees) will be examined. Tender-
ness will be assessed via participants’ self-report when 
light pressure is applied to the joint by the researcher. The 
degree of swelling will be visually assessed and self-re-
ported by the researcher. The number of swollen and 
tender joints will be used in conjunction with patients’ 
ESR and a self-reported degree of overall health ranging 
from 0 (very good) to 100 (very poor), to determine pa-
tients’ disease activity score-28 (DAS-28).91
Questionnaires. Validated questionnaires will be admin-
istered to the participant on visit 2 to assess RA-relat-
ed pain and fatigue during the study week (see Table 
2). Questionnaire scores will be calculated according to 
validated scoring instructions (e.g., pain scores from the 
McGill Pain Questionnaire will be calculated by summing 
the intensity rank values for descriptors of sensory, affec-
tive and total pain). 
Power Calculation
Power calculations were conducted with G*Power 
(version 3.1.9.3) using data collected from the Physi-
cal Activity in Rheumatoid Arthritis (PARA) randomised 
controlled trial (Trial Number: ISRCTN04121489). In the 
PARA study, accelerometers were utilised to measure 
SB, LPA and MVPA in a subsample of RA participants, 
and high-sensitivity CRP was measured as a biomarker 
of systemic inflammation. Cross-sectional accelerometer 
data were available for n = 61 participants. A priori power 
calculation from this data indicated that a sample size of 
n = 125 would be sufficient to detect statistically signifi-
cant relationships (power = 0.80, α error of probability = 
.05), between daily SB and LPA with high-sensitivity CRP 
(a key inflammatory biomarker in RA). 
To ensure the robustness of our calculations for detect-
ing significant changes in broader RA outcomes, we 
also conducted power calculations for physical function, 
overall cardiovascular risk score and vitality. For this, 
cross-sectional accelerometer data, Health Assess-
ment Questionnaire scores (physical function), QRisk-2 
scores (cardiovascular risk), and vitality scores (vitality) 
were available for n = 61, n = 61 and n = 59 participants 
respectively. A priori power calculation confirmed mini-
mum sample sizes of n = 82 (physical function), n = 14 
(QRisk-2) and n = 114 (vitality), would ensure adequate 
statistical power (power = 0.80, α error of probability = 
.05) to detect the hypothesised associations. 
Statistical Analyses
SPSS (version 24) will be used to compute descriptive 
statistics for all measured variables. These will include in-
formation regarding participant characteristics (e.g., gen-
der, mean age, ethnicity), health outcomes (e.g., DAS-28, 
BMI), determinants (e.g., quality of motivation, self-effica-
cy), as well as levels of SB and LPA among the RA sam-
ple. Missing value analyses will be conducted via multiple 
imputation92 or expectation maximization93 methods in 
SPSS, where missing data does not exceed 5%.
Cross-sectional associations between RA participants’ 
objectively-assessed SB patterns and LPA, with health 
outcomes (Aim 1) and proposed determinants (Aim 2) 
will be examined using correlation and regression anal-
yses. Longitudinal associations from baseline (Time 1) 
to 6-month follow-up (Time 2) will be analysed using re-
gression models.
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Table 2. Questionnaires administered at baseline (Time 1) and 6-month follow-up (Time 2), specifically on visit 2 to the 
hospital
Outcome Questionnaire Description Example
Pain McGill Pain Questionnaire
Questions pertaining to the past week
•	 17 items
- Sensory descriptors 
- Affective descriptors 
- Present pain 
- Average pain
•	 	For each of these words, please place a tick in 
one column:
- E.g., Throbbing
- (0 = none, to 3 = severe)
Fatigue Multidimensional Assessment of Fatigue 
Scale
Questions pertaining to the past week
•	 16 items
•	 4 dimensions:
- E.g., Degree and severity
•	 Global fatigue index
•	 	Please complete the following items based on the 
past week:
-  E.g., To what degree have you experienced 
fatigue? 
- (1 = not at all, to 10 = a great deal)
Fatigue Multidimensional Fatigue Inventory
Questions pertaining to the past week
•	 20 items
•	 5 dimensions:
- E.g., Physical fatigue
•	 Over the past week:
- E.g., I feel fit







Aim 1. For cross-sectional analyses, objectively-as-
sessed SB patterns and LPA will be independent vari-
ables. Dependent variables will include biomarkers of 
inflammation, disease activity, CVD risk, pain, fatigue, 
physical function, depression, anxiety, vitality, satisfac-
tion with life, positive and negative affect, and quality 
of life. For longitudinal analyses, regression models will 
examine if changes in objectively-assessed SB patterns 
significantly predict change in health outcomes from 
baseline (Time 1) to 6-month follow-up (Time 2). Health 
outcomes will be examined in separate regression mod-
els, but analyses will be adjusted for other factors which 
may influence these associations, as appropriate (e.g., 
disease duration, age, gender, current medication, and 
GT3X and activPAL3μTM wear time).
Aim 2. For cross-sectional analyses, the determinants of 
SB in RA (e.g., autonomy support and self-efficacy for 
physical activity, reducing SB and breaking up SB) will 
be independent variables, and objectively-assessed SB 
patterns and LPA in RA will be dependent variables. For 
longitudinal analyses, regression models will examine if 
changes in hypothesised determinants of SB and LPA 
(e.g., autonomy support for reducing SB) significantly 
predicts change in objectively-assessed SB patterns and 
LPA from baseline (Time 1) to 6-month follow-up (Time 
2). As above, all analyses will be adjusted for potential 
confounders (e.g., 7-day pain and fatigue [to consider 
the possibility of bi-directional relationships], GT3X and 
activPAL3μTM wear time).
Subsequent analyses will use AMOS (version 24) to 
conduct path analyses and structural equation model-
ling, in order to examine multivariate relationships and 
hypothesised process models. For example, psycho-
logical processes (e.g., autonomy support for reducing 
SB) proposed to underlie objectively-assessed accu-
mulated sedentary time and LPA engagement, in turn 
influencing RA disease outcomes (e.g., DAS-28) will be 
explored.37,45,94,95
DISCUSSION 
To date, there is a paucity of research on SB conducted in 
the RA population. The current study – investigating po-
tential physical and psychological health consequences, 
as well as potential determinants, of SB and LPA in RA 
patients – is taking steps to address the limitations of pre-
vious studies, whilst simultaneously addressing important 
knowledge gaps in the field. Firstly, this study is employing 
two novel devices to measure SB, according to the SB 
Research Network definition,11,12 and LPA in RA patients. 
The present study will also provide the first longitudinal ev-
idence regarding possible changes in health consequenc-
es associated with changes in sedentariness and LPA in 
this patient group. Furthermore, this longitudinal study is 
the first to comprehensively explore the determinants (i.e., 
psychosocial, individual differences and physical environ-
mental) of SB and LPA in RA. Indeed, this study will iden-
tify modifiable factors that might influence SB and LPA in 
this patient group above and beyond, for example, RA-re-
lated disease activity and physical function, which may 
demonstrate bi-directional associations with SB and LPA. 
These data will elucidate targets for intervention that have 
the potential to support people living with RA, to reduce 
their time spent sedentary (e.g., by regularly breaking up 
their sedentary time and displacing it with LPA).
Future Research Directions
Building on findings from this study, future research that 
aims to ascertain the health outcomes and determinants 
of SB in the RA population should be consistent in their 
approach. Specifically, studies should accurately define 
and conceptualise SB, and follow recommended proto-
cols that utilise validated measures (subjective and objec-
tive) to measure sedentariness and its correlates in RA.31 
Additionally, future research studies should seek to fur-
ther explore the ‘sedentary-inflammation hypothesis’,31 
which postulates cyclical relationships between SB, in-
flammation and adverse health outcomes in RA. Finally, 
interventions assessed by Randomised Controlled Trials 
must be developed, implemented and evaluated, to de-
finitively test the relationships in this study in order to infer 
causality. Data from the present study will generate an 
evidence base which will inform the development of such 
interventions, and optimise their potential to encourage 
SB change and improve health outcomes among people 
living with RA.
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